M
IMEPro
G54.0 Neurological
Updated March 2026

Brachial plexus disorders

ICD-10 Code: G54.0 · Body Part: Shoulder

QME Evaluation Process

Upper extremity neurological examination, EMG/NCS for plexopathy localization, MRI of brachial plexus. Rate peripheral nerve impairment per AMA Guides 5th Edition upper extremity tables.

Typical Impairment Rating

10-60% UE (6-36% WPI) depending on trunk involvement and motor deficit

AMA Guides Edition

5th Edition

Common Treatments

+ Physical therapy
+ Pain management
+ Nerve grafting
+ Tendon transfers

Related Conditions

Body Part Guide

Shoulder Evaluation Guide

Impairment rating methods, common conditions, and QME evaluation protocols

View Guide →

QME Specialties for Brachial plexus disorders

Find a QME Specialist

Browse QME-certified physicians who evaluate brachial plexus disorders and related shoulder conditions in California.

Browse Physical Medicine & Rehabilitation Physicians →

Frequently Asked Questions

What is Brachial plexus disorders (G54.0)?

Brachial plexus disorders is an ICD-10 diagnosis code (G54.0) classified under Neurological conditions. It affects the Shoulder and is commonly encountered in California workers' compensation claims. QME physicians evaluate this condition using AMA Guides 5th Edition protocols.

How is G54.0 rated for impairment?

The typical whole person impairment (WPI) range for Brachial plexus disorders is 10-60% UE (6-36% WPI) depending on trunk involvement and motor deficit. The exact rating depends on clinical findings, imaging, and the evaluation method (DRE or ROM) chosen by the QME physician per AMA Guides 5th Edition.

What is the QME evaluation process for G54.0?

Upper extremity neurological examination, EMG/NCS for plexopathy localization, MRI of brachial plexus. Rate peripheral nerve impairment per AMA Guides 5th Edition upper extremity tables.

What treatments are common for Brachial plexus disorders?

Common treatments for Brachial plexus disorders include Physical therapy, Pain management, Nerve grafting, Tendon transfers. Treatment appropriateness and outcomes are considered during the QME evaluation when determining permanent and stationary status and apportionment.